Neuroendocrine Tumor Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1566631 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Neuroendocrine Tumor Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Neuroendocrine Tumor Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Neuroendocrine Tumor Treatment Overall Market Size
    2.1 Global Neuroendocrine Tumor Treatment Market Size: 2021 VS 2028
    2.2 Global Neuroendocrine Tumor Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Neuroendocrine Tumor Treatment Players in Global Market
    3.2 Top Global Neuroendocrine Tumor Treatment Companies Ranked by Revenue
    3.3 Global Neuroendocrine Tumor Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Neuroendocrine Tumor Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Neuroendocrine Tumor Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Neuroendocrine Tumor Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Neuroendocrine Tumor Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Neuroendocrine Tumor Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Neuroendocrine Tumor Treatment Market Size Markets, 2021 & 2028
        4.1.2 Everolimus
        4.1.3 Sunitinib
        4.1.4 Lu-Dotatate
        4.1.5 Lanreotide
        4.1.6 Octreotide
    4.2 By Type - Global Neuroendocrine Tumor Treatment Revenue & Forecasts
        4.2.1 By Type - Global Neuroendocrine Tumor Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Neuroendocrine Tumor Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Neuroendocrine Tumor Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Neuroendocrine Tumor Treatment Revenue & Forecasts
        5.2.1 By Application - Global Neuroendocrine Tumor Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Neuroendocrine Tumor Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Neuroendocrine Tumor Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Neuroendocrine Tumor Treatment Revenue & Forecasts
        6.2.1 By Region - Global Neuroendocrine Tumor Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Neuroendocrine Tumor Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Neuroendocrine Tumor Treatment Revenue, 2017-2028
        6.3.2 US Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.3.3 Canada Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.3.4 Mexico Neuroendocrine Tumor Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Neuroendocrine Tumor Treatment Revenue, 2017-2028
        6.4.2 Germany Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.4.3 France Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.4.4 U.K. Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.4.5 Italy Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.4.6 Russia Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.4.8 Benelux Neuroendocrine Tumor Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Neuroendocrine Tumor Treatment Revenue, 2017-2028
        6.5.2 China Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.5.3 Japan Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.5.4 South Korea Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.5.6 India Neuroendocrine Tumor Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Neuroendocrine Tumor Treatment Revenue, 2017-2028
        6.6.2 Brazil Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.6.3 Argentina Neuroendocrine Tumor Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Neuroendocrine Tumor Treatment Revenue, 2017-2028
        6.7.2 Turkey Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.7.3 Israel Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Neuroendocrine Tumor Treatment Market Size, 2017-2028
        6.7.5 UAE Neuroendocrine Tumor Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Exelixis, Inc.
        7.1.1 Exelixis, Inc. Corporate Summary
        7.1.2 Exelixis, Inc. Business Overview
        7.1.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Major Product Offerings
        7.1.4 Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.1.5 Exelixis, Inc. Key News
    7.2 Advanced Accelerator Applications
        7.2.1 Advanced Accelerator Applications Corporate Summary
        7.2.2 Advanced Accelerator Applications Business Overview
        7.2.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Major Product Offerings
        7.2.4 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.2.5 Advanced Accelerator Applications Key News
    7.3 Dauntless Pharmaceuticals, Inc.
        7.3.1 Dauntless Pharmaceuticals, Inc. Corporate Summary
        7.3.2 Dauntless Pharmaceuticals, Inc. Business Overview
        7.3.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Major Product Offerings
        7.3.4 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.3.5 Dauntless Pharmaceuticals, Inc. Key News
    7.4 Hutchinson Medipharma Limited
        7.4.1 Hutchinson Medipharma Limited Corporate Summary
        7.4.2 Hutchinson Medipharma Limited Business Overview
        7.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Major Product Offerings
        7.4.4 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.4.5 Hutchinson Medipharma Limited Key News
    7.5 Ispen
        7.5.1 Ispen Corporate Summary
        7.5.2 Ispen Business Overview
        7.5.3 Ispen Neuroendocrine Tumor Treatment Major Product Offerings
        7.5.4 Ispen Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.5.5 Ispen Key News
    7.6 Novartis AG
        7.6.1 Novartis AG Corporate Summary
        7.6.2 Novartis AG Business Overview
        7.6.3 Novartis AG Neuroendocrine Tumor Treatment Major Product Offerings
        7.6.4 Novartis AG Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.6.5 Novartis AG Key News
    7.7 Progenics Pharmaceuticals, Inc.
        7.7.1 Progenics Pharmaceuticals, Inc. Corporate Summary
        7.7.2 Progenics Pharmaceuticals, Inc. Business Overview
        7.7.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Major Product Offerings
        7.7.4 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.7.5 Progenics Pharmaceuticals, Inc. Key News
    7.8 Tarveda Therapeutics
        7.8.1 Tarveda Therapeutics Corporate Summary
        7.8.2 Tarveda Therapeutics Business Overview
        7.8.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Major Product Offerings
        7.8.4 Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue in Global Market (2017-2022)
        7.8.5 Tarveda Therapeutics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Neuroendocrine Tumor Treatment Market Opportunities & Trends in Global Market
    Table 2. Neuroendocrine Tumor Treatment Market Drivers in Global Market
    Table 3. Neuroendocrine Tumor Treatment Market Restraints in Global Market
    Table 4. Key Players of Neuroendocrine Tumor Treatment in Global Market
    Table 5. Top Neuroendocrine Tumor Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Neuroendocrine Tumor Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Neuroendocrine Tumor Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Neuroendocrine Tumor Treatment Product Type
    Table 9. List of Global Tier 1 Neuroendocrine Tumor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Neuroendocrine Tumor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Neuroendocrine Tumor Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Neuroendocrine Tumor Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Neuroendocrine Tumor Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Neuroendocrine Tumor Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Neuroendocrine Tumor Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Neuroendocrine Tumor Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Exelixis, Inc. Corporate Summary
    Table 31. Exelixis, Inc. Neuroendocrine Tumor Treatment Product Offerings
    Table 32. Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Advanced Accelerator Applications Corporate Summary
    Table 34. Advanced Accelerator Applications Neuroendocrine Tumor Treatment Product Offerings
    Table 35. Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Dauntless Pharmaceuticals, Inc. Corporate Summary
    Table 37. Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Product Offerings
    Table 38. Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Hutchinson Medipharma Limited Corporate Summary
    Table 40. Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Product Offerings
    Table 41. Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Ispen Corporate Summary
    Table 43. Ispen Neuroendocrine Tumor Treatment Product Offerings
    Table 44. Ispen Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Novartis AG Corporate Summary
    Table 46. Novartis AG Neuroendocrine Tumor Treatment Product Offerings
    Table 47. Novartis AG Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Progenics Pharmaceuticals, Inc. Corporate Summary
    Table 49. Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Product Offerings
    Table 50. Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Tarveda Therapeutics Corporate Summary
    Table 52. Tarveda Therapeutics Neuroendocrine Tumor Treatment Product Offerings
    Table 53. Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Neuroendocrine Tumor Treatment Segment by Type in 2021
    Figure 2. Neuroendocrine Tumor Treatment Segment by Application in 2021
    Figure 3. Global Neuroendocrine Tumor Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Neuroendocrine Tumor Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Neuroendocrine Tumor Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Neuroendocrine Tumor Treatment Revenue in 2021
    Figure 8. By Type - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 12. US Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 24. China Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Neuroendocrine Tumor Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Neuroendocrine Tumor Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Ispen Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Novartis AG Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Neuroendocrine Tumor Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuroendocrine Tumor Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuroendocrine Tumor Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports